MRM Health Initiates Clinical Research in Parkinsons Disease

MRM Health a clinicalstage biopharmaceutical company announced today that it has received regulatory and ethics committee approval to start an observational crosssectional clinical trial to study the role of the small intestinal microbiome in Parkinsons Disease PD and to identify PDspecific microbial and metabolic fingerprints in small intestinal fluid and blood.

Related Keywords

Canada ,Belgium ,Calgary ,Alberta ,Sabina Bruehlmann ,Sam Possemiers ,Davide Martino ,Christiane Verhaegen ,Nimble Science Inc ,University Of Calgary ,Calgary Parkinson Research Initiative ,Gi Health ,Calgary Parkinson Research Initiative Ca ,Nimble Science ,Calgary Parkinson ,Research Initiative ,Ulcerative Colitis ,Inflammatory Bowel Diseases ,Chief Executive Officer ,Principal Investigator ,Small Intestine Microbiome Aspiration ,Media Contact ,Mrm Health Clinical Research Parkinsons Disease Trial Biopharmaceutical Nimble Science Collaboration University Of Calgary Study Healthy Volunteer Initiative Capri Dr Davide Martino Clinicaltrials Nct06003608 Coral Technology Ulcerative Colitis Inflammatory Bowel Diseases Iff Nutrition Biosciences Sam Possemiers Sabina Bruehlmann ,